Adjuvant chemotherapy in upper tract urothelial carcinoma (the POUT trial): a phase 3, open-label, randomised controlled trial

BACKGROUND: Urothelial carcinomas of the upper urinary tract (UTUCs) are rare, with poorer stage-for-stage prognosis than urothelial carcinomas of the urinary bladder. No international consensus exists on the benefit of adjuvant chemotherapy for patients with UTUCs after nephroureterectomy with cura...

Descripción completa

Detalles Bibliográficos
Autores principales: Birtle, Alison, Johnson, Mark, Chester, John, Jones, Robert, Dolling, David, Bryan, Richard T, Harris, Christopher, Winterbottom, Andrew, Blacker, Anthony, Catto, James W F, Chakraborti, Prabir, Donovan, Jenny L, Elliott, Paul Anthony, French, Ann, Jagdev, Satinder, Jenkins, Benjamin, Keeley, Francis Xavier, Kockelbergh, Roger, Powles, Thomas, Wagstaff, John, Wilson, Caroline, Todd, Rachel, Lewis, Rebecca, Hall, Emma
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181180/
https://www.ncbi.nlm.nih.gov/pubmed/32145825
http://dx.doi.org/10.1016/S0140-6736(20)30415-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7181180/
https://www.ncbi.nlm.nih.gov/pubmed/32145825
http://dx.doi.org/10.1016/S0140-6736(20)30415-3

Ejemplares similares